© 2023 BioMarin. All rights reserved.

Financial Statements

NASDAQBMRN
All numbers in thousands USD
Period Ending
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Total Revenue
2,096,039
1,846,275
1,860,461
--
Cost of Revenue
483,669
470,515
524,272
--
Gross Profit
1,612,370
1,375,760
1,336,189
--
Operating Expenses
Research Development
649,606
628,793
628,116
--
Selling General and Administrative
854,009
759,400
737,700
--
Non Recurring
--
--
--
--
Others
67,193
61,900
62,200
--
Total Operating Expenses
1,570,808
1,450,093
1,428,016
--
Operating Income or Loss
41,562
(74,333)
(91,827)
--
Income from Continuing Operations
Total Other Income/Expenses Net
105,950
3,846
62,137
--
Earnings Before Interest And Taxes
164,953
(60,606)
(13,013)
--
Interest Expense
15,377
14,744
29,309
--
Income Before Tax
149,576
(75,350)
(42,322)
--
Income Tax Expense
8,015
(11,270)
(901,422)
--
Minority Interest
--
--
--
--
Net Income From Continuing Ops
141,561
(64,080)
859,100
--
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
0
0
--
Net Income
141,561
(64,080)
859,100
--
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
141,561
(64,080)
859,100
--